🟢 Connect Biopharma is trading 6.43% up today in after-hours trading with no verified late-breaking catalyst identified

Connect Biopharma is trading at $2.65, up 6.43%, after no verified late-breaking catalyst was identified.

• It closed at $2.49 on August 17, 2026; no new company-specific announcement was identified that day.
• The latest material update, released August 12, reported completed enrollment in two Phase 2 studies, with topline results expected in September 2026.
• The broader market finished lower, and with no volume data, the reason remains uncertain.